SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -467.1% | – | -86.7% | +391.9% | +1,126.7% | +3,103.1% | -105.0% | – | -153.7% | – | |
| – | -19.6% | -18.5% | -8.1% | +5.2% | -6.2% | -16.2% | +2,050.9% | +80.3% | -7.6% | -21.6% | -8.7% | |
| – | +231.7% | +153.0% | -59.4% | +339.7% | -30.2% | +239.8% | -24.2% | +1,832.6% | -100.0% | – | – | |
| – | +7.2% | -86.7% | +6,948.4% | +177.2% | -29.8% | +367.7% | – | – | – | – | – | |
| – | – | – | – | -319.4% | – | – | +62.9% | -334.7% | – | -144.4% | – | |
| – | -51.4% | +138.8% | -5.8% | -52.9% | +89.3% | +1,101.1% | +464.0% | -44.0% | -63.9% | -33.0% | -49.9% | |
| – | -59.0% | +160.8% | +1.0% | +112.3% | +68.1% | +382.3% | +1,376.7% | +90.5% | -49.2% | – | – | |
| – | -100.0% | – | – | – | – | – | – | -86.0% | +24.7% | +188.6% | +271.0% | |
| – | +33.9% | -58.0% | +437.1% | +4,945.4% | – | – | – | – | – | – | – | |
| – | -2,179.1% | – | -127.3% | +343.7% | -95.2% | – | -104.6% | -83.5% | – | -48.5% | -19.0% | |
| – | -555.8% | – | -104.8% | – | -97.3% | +34,014.3% | -420.1% | -87.3% | -68.5% | +983.2% | +316.9% | |
| – | – | – | – | -16.5% | -105.4% | – | +1,081.8% | -169.4% | – | – | – | |
| – | – | – | – | -95.1% | +1,120.9% | +1,136.2% | +4,061.0% | -108.0% | – | – | – |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.